SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 375.76 |
| Enterprise Value ($M) | 198.90 |
| Book Value ($M) | 169.24 |
| Book Value / Share | 4.72 |
| Price / Book | 2.22 |
| NCAV ($M) | 148.49 |
| NCAV / Share | 4.14 |
| Price / NCAV | 2.53 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.65 |
| Return on Assets (ROA) | -1.04 |
| Return on Equity (ROE) | -1.41 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.84 |
| Current Ratio | 7.84 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 179.18 |
| Assets | 199.93 |
| Liabilities | 30.69 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -126.14 |
| Net Income | -117.25 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -96.59 |
| Cash from Investing | -2.22 |
| Cash from Financing | 163.80 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | State Street Corp | 12.50 | ||
| 13G/A | Baker Bros. Advisors Lp | 5.90 | 0.21 | |
| 13G/A | Janus Henderson Group Plc | 4.80 | -37.68 | |
| 13G/A | Butler Thomas Andrew | 10.40 | 10.13 | |
| 13G/A | Erdtmann Rainer M | 7.80 | 4.21 | |
| 13G/A | Fmr Llc | 15.00 | 7.23 | |
| 13G | Laurion Capital Management LP | 7.66 | ||
| 13G | BlackRock Inc. | 6.00 | 148.71 | |
| 13D/A | Cormorant Global Healthcare Master Fund, LP | 10.16 | 13.19 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 91,621 | 405,966 | 22.57 | |
| 87,800 | 336,872 | 26.06 | |
| 122,134 | 351,865 | 34.71 | |
| 98,725 | 297,224 | 33.22 | |
| 138,149 | 262,568 | 52.61 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BEAM – Beam Therapeutics Inc. | BIIB – Biogen Inc. |
| BLUE – bluebird bio, Inc. | BMRN – BioMarin Pharmaceutical Inc. |
| BOLT – Bolt Biotherapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io